The wound/burn guidelines - 5: Guidelines for the management of lower leg ulcers/varicose veins

Venous Leg Ulcers: A Review of Published Assessment and Treatment Algorithms

Significance: Chronic venous disease (CVD) is prevalent in the aging population and leads to venous leg ulcers (VLUs). These wounds can last and recur for years, significantly impacting quality of life. A large body of literature exists on CVD and VLU diagnosis and treatment. Multiple algorithms, guidelines, and consensus documents have been published on this topic, highlighting the importance of this issue in clinical practice. However, these documents are not fully aligned with each other. Recent Advances: The latest update of the internationally used classification system for CVD was recently published. Our review aims to summarize the existing information to provide an educational tool for clinicians new to this topic, and to highlight the commonalities between the published recommendations. Critical issues: VLUs need to be treated with consideration for the extent of venous disease present in the patient. This requires a good understanding of the various components involved and the possible additional concomitant conditions by the first-line clinician who encounters the patient. A multidisciplinary team is necessary for a successful overall treatment plan, and this plan should be tailored to each patient's specific needs and lifestyle. Future Directions: Compression is still the mainstay of treatment for CVD and VLUs. Compression is needed long term, but it does not suffice by itself to prevent recurrences without interventional correction. Venous intervention should be offered early to prevent or slow disease progression and reduce recurrence.

An estimate of the economic burden of venous leg ulcers associated with deep venous obstruction

Introduction:

Venous leg ulcers (VLU) embody the most severe stage of the broad spectrum of chronic venous disease. Approximately 40% of patients with VLU present with the underlying deep venous disease (DVD). Although the data are scarce, these deep venous disease-related VLU (DRV) are thought to have higher recurrence rates and a substantial economic burden. The objective of this study was to assess the economic burden of DRV across Australia, France, Germany, Italy, Spain, the UK, and the USA.

Methods:

A comprehensive literature review was undertaken to identify publications documenting the incidence and prevalence of VLU and DRV, medical resource utilization, and associated costs of DRV. Findings from this literature review were used to estimate the economic burden of illness, including direct medical costs over a 12-month interval following initial presentation of a newly formed DRV.

Results:

Total annual incidence of new or recurrent DRV in Australia, France, Germany, Italy, Spain, UK, and the US are estimated at 122,000, 263,000, 345,000, 253,000, 85,000, 230,000, and 643,000 events, respectively, in 2019. Incidence ranges from 0.73 to 3.12 per 1000 persons per year. The estimated annual direct medical costs for patients managed conservatively in these geographies total ~ $10.73 billion (USD) or $5527 per person per year.

Conclusion:

The availability of published data on the costs of VLU care varies widely across countries considered in this analysis. Although country-specific VLU practice patterns vary, there is a uniform pattern of high-cost care.

The role of Smad7 in cutaneous wound healing

Chronic refractory wounds are generally caused by local tissue defects and necrosis, and they are characterized by delayed wound healing as well as high recurrence, which seriously affects life quality. However, effective therapeutics to treat wounds are currently unavailable. Therapy primarily aims to accelerate generation of granulation tissue and decrease recurrence. The pathogenesis of chronic refractory wounds is closely related to multiple complex signaling pathways and a series of cytokines. Among these signaling pathways, TGF-β/Smad7 axis plays a critical role. Specifically, Smad7 is an antagonist of TGF-β that inhibits activation of TGF-β. Moreover, Smad7 promotes wound healing by regulating cytokines and controlling growth, differentiation and apoptosis of cells, which may be exploited to cure the disease. This review aims to reveal the exact functions and mechanisms of Smad7 in regulation of wound healing.

Usefulness of the advanced monoenergetic image reconstruction in dual-energy computed tomography for detecting the perforator vein of lower extremity varix

Background

Identification of the perforator vein is important for treating lower extremity varix.

Purpose

We evaluated the ability of 40-keV advanced monoenergetic images to depict the perforator vein in patients with lower extremity varix.

Material and Methods

Thirty-three patients aged 52–86 years were examined with contrast-enhanced dual-energy computed tomography (CT) and advanced virtual monoenergetic images (40 keV) were reconstructed. For evaluating enhancement of a lower extremity vein and the difference in CT number between the vein and muscle, we set the region of interest on the popliteal vein (PV). We also evaluated the ability of 100-kVp and 40-keV volume-rendering (VR) images to depict the perforator veins.

Results

The mean CT numbers of the PV at 100 kVp and 40 keV were 113 ± 16 and 321 ± 63 HU, respectively (P < 0.01). In 40-keV transverse images of 33 patients, 84 of the perforator veins were detected. In those 84 veins, 70 (83%) were depicted and 14 (17%) were not depicted on VR images that were reconstructed from 40-keV transverse images. At 100 kVp, 10 (12%) of the perforator veins could be depicted in VR images because the muscles buried them or the PVs were blurred due to insufficient enhancement.

Conclusion

The advanced monoenergetic reconstruction technique is useful for evaluating the perforator vein in patients with lower extremity varix.